Showing results (61-70 of 69) with videos related to
Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
IJID Regions|July 7, 2023
Outcomes among Thai children with risk conditions hospitalized for pneumococcal disease (invasive or non-bacteraemic pneumonia): A multi-centre, observational studyWanatpreeya Phongsamart, Kristen E Allen, Warunee Punpanich Vandepitte, et al.Journal of the Royal Society of Medicine|July 5, 2023
Impact of SARS-CoV-2 infective exacerbation of chronic obstructive pulmonary disease on clinical outcomes in a prospective cohort study of hospitalised adultsCatherine Hyams, George Qian, George Nava, et al.Eclinicalmedicine|December 6, 2021
Effectiveness of BNT162b2 mRNA COVID-19 vaccine against SARS-CoV-2 variant Beta (B.1.351) among persons identified through contact tracing in Israel: A prospective cohort studyShepherd R Singer, Frederick J Angulo, David L Swerdlow, et al.Nursing Reports (Pavia, Italy)|June 25, 2025
Embracing Growth, Adaptability, Challenges, and Lifelong Learning: A Qualitative Study Examining the Lived Experience of Early Career NursesLiz Ryan, Di Stratton-Maher, Jessica Elliott, et al.The Lancet Regional Health. Europe|August 15, 2022
Incidence of community acquired lower respiratory tract disease in Bristol, UK during the COVID-19 pandemic: A prospective cohort studyCatherine Hyams, Robert Challen, Elizabeth Begier, et al.International Journal of Nursing Studies|February 25, 2026
Re-imagining nursing education: Mapping student learning, transition, and workforce readiness - A scoping reviewDianne Stratton-Maher, Tracey Tulleners, Jessica Elliott, et al.BJGP Open|September 9, 2024
Estimating the burden of vaccine-preventable lower respiratory tract disease in UK primary care: protocol for a prospective surveillance study (AvonCAP GP2)Polly Duncan, Ruth Mears, Elizabeth Begier, et al.BMJ Open|January 14, 2025
Cohort profile: the potentially preventable burden of community-acquired pneumonia in South African adults in the era of widespread PCV13 immunisation and antiretroviral therapy roll-out, before and during the COVID-19 pandemic - the multicentre, multimethod PotPrev StudyFirdaus Nabeemeeah, Nadia Sabet, Kennedy Otwombe, et al.The Lancet. Infectious Diseases|September 4, 2018
Prognostic value of interferon-γ release assays and tuberculin skin test in predicting the development of active tuberculosis (UK PREDICT TB): a prospective cohort studyIbrahim Abubakar, Francis Drobniewski, Jo Southern, et al.Pageof 7